FR2131248A5 - - Google Patents

Info

Publication number
FR2131248A5
FR2131248A5 FR7139256A FR7139256A FR2131248A5 FR 2131248 A5 FR2131248 A5 FR 2131248A5 FR 7139256 A FR7139256 A FR 7139256A FR 7139256 A FR7139256 A FR 7139256A FR 2131248 A5 FR2131248 A5 FR 2131248A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7139256A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crinos Industria Farmacobiologica SpA
Original Assignee
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmacobiologica SpA filed Critical Crinos Industria Farmacobiologica SpA
Application granted granted Critical
Publication of FR2131248A5 publication Critical patent/FR2131248A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR7139256A 1970-11-03 1971-11-02 Expired FR2131248A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT31308/70A IT1043823B (it) 1970-11-03 1970-11-03 Procedimento per l estrazione di acidi nucleici da organi animali

Publications (1)

Publication Number Publication Date
FR2131248A5 true FR2131248A5 (enExample) 1972-11-10

Family

ID=11233430

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7139257A Expired FR2131249A5 (enExample) 1970-11-03 1971-11-02
FR7139256A Expired FR2131248A5 (enExample) 1970-11-03 1971-11-02

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7139257A Expired FR2131249A5 (enExample) 1970-11-03 1971-11-02

Country Status (7)

Country Link
US (1) US3770720A (enExample)
JP (1) JPS5229320B1 (enExample)
DE (2) DE2154278A1 (enExample)
FR (2) FR2131249A5 (enExample)
GB (2) GB1367656A (enExample)
IT (1) IT1043823B (enExample)
SE (2) SE385376B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006235A1 (en) * 1986-04-17 1987-10-22 Crinos Industria Farmacobiologica Spa A process for obtaining chemically defined and reproducible polydeoxyribonucleotides

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5967214A (ja) * 1982-10-12 1984-04-16 Kazuo Suga 化粧品組成物
DE3380342D1 (en) * 1982-10-26 1989-09-14 Cta Finanz Ag Device and process for optimising the tissue mass of organs within the genetic fluctuation range in humans and animals
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
IT1187833B (it) * 1985-12-12 1987-12-23 Farmigea Spa Procedimento per l ottenimento di polidesossiribonucleotidi non informazionali sostanzialmente puri e dotati di attivita biologiche e prodotto relativo
IT1212143B (it) 1987-06-26 1989-11-08 Crinos Industria Farmaco Composizione ad attivita'tricogena.
IT1222701B (it) * 1987-09-23 1990-09-12 Crinos Industria Farmaco Composizione ad uso topico avente attivita' tricogena,antiforfora ed antiseborroica
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
US6699985B2 (en) 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
CA2299119C (en) * 1999-02-23 2013-02-05 Qiagen Gmbh A method of stabilizing and/or isolating nucleic acids
DK1059092T3 (da) 1999-06-08 2006-03-27 Gentium Spa Anvendelse af komplekser af kationiske liposomer og polydeoxyribonukleotider som medikamenter
US6323743B1 (en) * 1999-08-24 2001-11-27 Tresness Irrevocable Patent Trust Electronic filter assembly
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
EP1147777A1 (en) * 2000-04-18 2001-10-24 Crinos Industria Farmacobiologica S.p.A. Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
MX2007010754A (es) * 2005-03-03 2007-11-07 Gentium Spa Defibrotide y/u oligodeoxiribonucleotidos para tratar tumores dependientes de angiogenesis.
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
JP6069209B2 (ja) 2010-11-12 2017-02-01 ジェンティウム ソシエタ ア レスポンサビリタ リミタータ 移植片対宿主病（ｇｖｈｄ）の予防および／または治療に使用するためのデフィブロタイド
ES2660969T5 (es) 2012-06-22 2021-09-03 Gentium S R L Método basado en euglobulina para determinar la actividad biológica de defibrotida
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
EP3661484A1 (en) 2017-08-03 2020-06-10 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
WO2019200251A1 (en) 2018-04-12 2019-10-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
US20220023533A1 (en) 2018-12-07 2022-01-27 Jazz Phrmaceticals Ireland Limited Subcutaneous delivery of high concentration formulations
US20230190783A1 (en) 2020-02-28 2023-06-22 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
EP4135717A1 (en) 2020-04-17 2023-02-22 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006235A1 (en) * 1986-04-17 1987-10-22 Crinos Industria Farmacobiologica Spa A process for obtaining chemically defined and reproducible polydeoxyribonucleotides
FR2597481A1 (fr) * 1986-04-17 1987-10-23 Crinos Industria Farmaco Procede pour obtenir des polydesoxyribonucleotides chimiquement definis et reproductibles.
US4985552A (en) * 1986-04-17 1991-01-15 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
BE1002908A4 (fr) * 1986-04-17 1991-07-30 Crinos Industria Farmaco Procede pour obtenir des polydesoxyribonucleotides chimiquement definis et reproductibles.

Also Published As

Publication number Publication date
JPS5229320B1 (enExample) 1977-08-01
GB1366647A (en) 1974-09-11
DE2154277A1 (de) 1972-05-25
DE2154277C2 (enExample) 1988-04-07
SE385902B (sv) 1976-07-26
GB1367656A (en) 1974-09-18
IT1043823B (it) 1980-02-29
SE385376B (sv) 1976-06-28
DE2154278A1 (de) 1972-05-25
FR2131249A5 (enExample) 1972-11-10
US3770720A (en) 1973-11-06

Similar Documents

Publication Publication Date Title
ATA96471A (enExample)
AU2044470A (enExample)
AU1146470A (enExample)
AU1473870A (enExample)
AU2130570A (enExample)
AU2085370A (enExample)
AU2017870A (enExample)
AU1833270A (enExample)
AU1716970A (enExample)
AU1326870A (enExample)
AU1517670A (enExample)
AU1336970A (enExample)
AR195465A1 (enExample)
AU1591370A (enExample)
AU1872870A (enExample)
AU2144270A (enExample)
ATA672271A (enExample)
AU1328670A (enExample)
AU2130770A (enExample)
AU1343870A (enExample)
AU1277070A (enExample)
AU1004470A (enExample)
AU1247570A (enExample)
AU1581370A (enExample)
AU2119370A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse